Ayer Lab

Expertise in the Study of Leukemia

The Deininger/O'Hare lab expertise is in the study of leukemia. The lab's research program focuses on the biology of myeloproliferative neoplasms and the development of molecularly targeted therapies. We are especially interested in understanding the molecular mechanisms of resistance to tyrosine kinase inhibitors such as imatinib, a drug used to treat chronic myeloid leukemia and some other types of cancer.

Now seeking post-doctoral scholar. Apply here.

News & Blog

4
Huntsman Cancer Institute Investigator Recognized Among World's Most Cited Researchers
Research
Nov 21, 2014

Huntsman Cancer Institute Investigator Recognized Among World's Most Cited Researchers

Huntsman Cancer Institute,

Michael Deininger, MD, PhD, a Huntsman Cancer Institute (HCI) investigator and professor of internal medicine at the University of Utah, has been listed among the world’s Highly Cited Researchers in 2014 by Thomson Reuters, an international media firm. The list includes more than 3,000 authors worldwide in 21 science and social science fields, representing the top 1% of authors most cited in their specialty areas for the years 2002 to 2012.... Read More